Review
Nature Reviews Cancer 4, 948-955 (December 2004) | doi:10.1038/nrc1501
Focus on: kinases
Regulation of the cytoskeleton: an oncogenic function for cdk inhibitors?
Arnaud Besson1, Richard K. Assoian2 & James M. Roberts1,3 About the authors
Abstract
Cyclin-dependent kinase inhibitors (CKIs) are well known inhibitors of cell proliferation. Their activity is disrupted in many tumour types. Recent studies show that some of these proteins have interesting alternative functions, acting in the cytoplasm to regulate Rho signalling and thereby controlling cytoskeletal organization and cell migration. The upregulation of CKIs in the cytoplasm of many cancer cells indicates that although loss of nuclear CKIs is important for cancer cell proliferation, gain of cytoplasmic CKI function might be involved in tumour invasion and metastasis.
- View At a Glance
Author affiliations
- Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Division of Basic Science, Seattle, Washington 98109, USA.
- Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
- Fred Hutchinson Cancer Research Center, Division of Basic Science, Mail stop A3-020, 1100 Fairview Avenue North, Seattle, Washington 98109, USA.
Correspondence to: James M. Roberts1,3 Email: jroberts@fhcrc.org
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Cdk5 checks p27 kip1 in neuronal migrationNature Cell Biology News and Views (01 Jan 2006)
Cancer Kip movingNature News and Views (15 Apr 2004)
See all 4 matches for News And ViewsRESEARCH
Stability of p21 Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeletonOncogene Original Article
α-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progressionLaboratory Investigation Research Article
See all 52 matches for Research